Lessons Learned from HIV Vaccine Clinical Efficacy Trials

Por Day, Tracey A., Kublin, James G.
Publicado em 2013

HIV Vaccine Trials Network: activities and achievements of the first decade and beyond

Por Kublin, James G, Morgan, Cecilia A, Day, Tracey A, Gilbert, Peter B, Self, Steve G, McElrath, M Juliana, Corey, Lawrence
Publicado em 2012

Tuberculosis Vaccines and Prevention of Infection

Por Hawn, Thomas R., Day, Tracey A., Scriba, Thomas J., Hatherill, Mark, Hanekom, Willem A., Evans, Thomas G., Churchyard, Gavin J., Kublin, James G., Bekker, Linda-Gail, Self, Steven G.
Publicado no Microbiol Mol Biol Rev (2014)

Mycobacterium tuberculosis Strains Lacking Surface Lipid Phthiocerol Dimycocerosate Are Susceptible to Killing by an Early Innate Host Response

Por Day, Tracey A., Mittler, John E., Nixon, Molly R., Thompson, Cullen, Miner, Maurine D., Hickey, Mark J., Liao, Reiling P., Pang, Jennifer M., Shayakhmetov, Dmitry M., Sherman, David R.
Publicado no Infect Immun (2014)

A structure-function approach to optimizing TLR4 ligands for human vaccines

Por Carter, Darrick, Fox, Christopher B, Day, Tracey A, Guderian, Jeffrey A, Liang, Hong, Rolf, Tom, Vergara, Julie, Sagawa, Zachary K, Ireton, Greg, Orr, Mark T, Desbien, Anthony, Duthie, Malcolm S, Coler, Rhea N, Reed, Steven G
Publicado no Clin Transl Immunology (2016)